Evidence map›Paper›PMID 25448067›Full record

ArticleStem cell reports2014

Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions.

Gene Uenishi, Derek Theisen, Jeong-Hee Lee, Akhilesh Kumar, Matt Raymond, Maxim Vodyanik, Scott Swanson, Ron Stewart, James Thomson, Igor Slukvin

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Gene UenishiDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53792, USA.
Derek TheisenWisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA.
Jeong-Hee LeeWisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA.
Akhilesh KumarWisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA.
Matt RaymondWisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA.
Maxim VodyanikWisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA.
Scott SwansonMorgridge Institute for Research, Madison, WI 53707, USA.
Ron StewartMorgridge Institute for Research, Madison, WI 53707, USA.
James ThomsonMorgridge Institute for Research, Madison, WI 53707, USA; Department of Cell and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53707, USA; Department of Molecular, Cellular & Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
Igor SlukvinDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53792, USA; Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA. Electronic address: islukvin@wisc.edu.
University of Wisconsin–Madison · USMorgridge Institute for Research · US

Funding

WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
Midwest Progenitor Cell ConsortiumU01HL099773 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI THOMSON, JAMES ALEXANDER · 2009 to 2015
$7.8M
iPSC-based blood regenerative therapies for AIDSR01HL116221 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI SLUKVIN, IGOR I., TORBETT, BRUCE EDWARD · 2013 to 2017
$3.4M
NCRR NIH HHS P51 RR000167NHLBI NIH HHS R01 HL116221NHLBI NIH HHS R01HL116221NHLBI NIH HHS U01 HL099773NHLBI NIH HHS U01HL099773NIH HHS P51 OD011106
6 · The paper itself

Abstract

The recent identification of hemogenic endothelium (HE) in human pluripotent stem cell (hPSC) cultures presents opportunities to investigate signaling pathways that are essential for blood development from endothelium and provides an exploratory platform for de novo generation of hematopoietic stem cells (HSCs). However, the use of poorly defined human or animal components limits the utility of the current differentiation systems for studying specific growth factors required for HE induction and manufacturing clinical-grade therapeutic blood cells. Here, we identified chemically defined conditions required to produce HE from hPSCs growing in Essential 8 (E8) medium and showed that Tenascin C (TenC), an extracellular matrix protein associated with HSC niches, strongly promotes HE and definitive hematopoiesis in this system. hPSCs differentiated in chemically defined conditions undergo stages of development similar to those previously described in hPSCs cocultured on OP9 feeders, including the formation of VE-Cadherin(+)CD73(-)CD235a/CD43(-) HE and hematopoietic progenitors with myeloid and T lymphoid potential.

Indexed as

AnimalsCell Culture TechniquesCell DifferentiationCell LineageCells, CulturedCluster AnalysisCoculture TechniquesCulture MediaGene Expression ProfilingHemangioblastsHematopoiesisHumansMesodermMicePluripotent Stem CellsPrecursor Cells, T-LymphoidCulture MediaTenascin

Identifiers

PMID25448067
PMCPMC4263995
OpenAlexW2140119219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.